Centre Hospitalier de l'Universite de Vaudois, Lausanne
Head and neck cancer treated by amifostine therapy combined with radiotherapy
Published in Cancer Law Weekly, April 8th, 2006
According to a recently published article, scientists in Switzerland conducted a study "to assess the feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated RT."
"Thirty-three consecutive patients [were studied] (male-female ratio, 4.5; median age, 54 years [age range, 39-76 years])," explained M. Ozsahin and colleagues, Centre Hospitalier de l'Universite de Vaudois. "Between November 2000 and January 2003, the 33 patients were treated with curative...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-04-08)
More Articles from Cancer Law Weekly
- Advaxis, Inc.
Advaxis receives approvals to commence study of Listeria vaccine for cervical cancer - Arius Research, Inc.
U.S. patent issued to Arius Research for anti-CD63 antibody for cancer treatment - Braintree Laboratories, Inc.
Braintree Laboratories in-licenses rights to chemoprevention agent against colorectal cancer - Dana-Farber Cancer Institute, Boston
Ovarian cancer patients treated by gynecologic oncologists had better outcomes - DiagnoCure, Inc.
DiagnoCure wins U.S. patent for PCA3 - John Wiley & Sons, Inc.
Disclosing study outcomes to participants may backfire - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
